Preclinical evaluation of XPO1 inhibition in Wilms tumors.

被引：0
|
作者：
Ortiz, Michael Vincent
Siddiquee, Armaan
You, Daoqi
Mundi, Prabhjot Singh
Marks, Lianna Q.
Guillan, Kristina
Diolaiti, Daniel
Aburi, Mahalaxmi
Califano, Andrea
Dela Cruz, Filemon S.
Kung, Andrew
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Columbia Univ, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3580
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma
    Graves, Laurie
    Rupprecht, Gabrielle
    Altunel, Erdem
    Flamant, Etienne M.
    Rao, Sneha
    Sivara, Dharshan
    Lazarides, Alexander L.
    Hoskinson, Sarah M.
    Sheth, Maya U.
    Cheng, Serene
    Kim, So Young
    Ware, Kathryn E.
    Agarwal, Anika
    Cullen, Mark M.
    Syal, Casey
    Selmic, Laura E.
    Everitt, Jeffrey I.
    McCall, Shannon J.
    Eward, Cindy
    Kashyap, Trinayan
    Maloof, Marie
    Walker, Christopher J.
    Landesman, Yosef
    Wagner, Lars
    Eward, William C.
    Hsu, David S.
    Somarelli, Jason A.
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
    Rahman, Masmudur M.
    Estifanos, Bereket
    Glenn, Honor L.
    Gutierrez-Jensen, Ami D.
    Kibler, Karen
    Li, Yize
    Jacobs, Bertram
    Mcfadden, Grant
    Hogue, Brenda G.
    VIRUSES-BASEL, 2025, 17 (02):
  • [23] Viewpoint Exportin(g) precision oncology beyond genomics with XPO1 inhibition
    Gouda, Mohamed A.
    Subbiah, Vivek
    MED, 2022, 3 (11): : 730 - 732
  • [24] XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
    Galinski, Basia
    Luxemburg, Marcus
    Landesman, Yosef
    Pawel, Bruce
    Johnson, Katherine J.
    Master, Stephen R.
    Freeman, Kevin W.
    Loeb, David M.
    Hebert, Jean M.
    Weiser, Daniel A.
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [25] XPO1 and BRAF Inhibition Synergize and Modulate pRb, Survivin and ERK in Melanoma
    Fragomeni, R. A. Salas
    Cusack, J. C.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S91 - S91
  • [26] Preclinical evaluation of XPO1 inhibition with topoisomerase-I (topo-I) inhibition in colorectal cancer (CRC) cell lines and patient-derived xenograft (PDX) models
    Lentz, Robert W.
    Dominguez, Adrian
    Bagby, Stacey
    Binns, Cameron
    Leal, Alexis
    Kim, Sunnie
    Davis, Sarah Lindsey
    Lieu, Christopher H.
    Messersmith, Wells A.
    Pitts, Todd M.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [27] Redirecting traffic using the XPO1 police
    Abraham, Sheela A.
    Holyoake, Tessa L.
    BLOOD, 2013, 122 (17) : 2926 - 2928
  • [28] Nuclear exporter protein exportin 1 (XPO1) as a novel therapeutic target in pancreatic neuroendocrine tumors
    Azmi, A. S.
    Uddin, M. H.
    Bannoura, S. F.
    Khan, H. M.
    Diab, M.
    Kim, S.
    Beal, E.
    Tobon, M.
    Chen, H.
    Beydoun, R.
    Dyson, G.
    Mohammad, R. M.
    Philip, P. A.
    Al-Hallak, M. N.
    El-Rayes, B. F.
    Pasche, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S97 - S97
  • [29] Melphalan and XPO1 inhibition are synergistic in pre-clinical models of multiple myeloma
    Turner, Joel G.
    Dawson, Jana L.
    Sullivan, Daniel M.
    CANCER RESEARCH, 2016, 76
  • [30] XPO1 Inhibitor Approved for Multiple Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (09) : 1150 - 1151
12345